Quebec-based Merck Canada today announced Health Canada approved an expanded indication of GARDASIL®9 in individuals 9 through 45 years of age to prevent infection caused by the Human Papillomavirus (HPV) types 6, 11, 16, 18, 31, 33, 45, 52, and 58. And this approval is…
With a dramatically increasing incidence of HPV-related head and neck cancers in North America, dentistry is the first aggressive line of defense, and now offense, in saving lives and protecting quality of life. From this webinar, we hope that dentists…
View Print Edition
View Digital Edition
View Special Edition